PCN56 Benchmarking Use in Economic Value Assessment of Oncologic Drugs-Example of Cabacitaxel
Abstract
Authors
T. Foltanova E. Tainova D. Tomek V. Foltan
T. Foltanova E. Tainova D. Tomek V. Foltan
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now